Introduction
In the pig, establishment of pregnancy begins about 11\p=n-\12 days after the start of oestrus (Dhindsa & Dziuk, 1968) . The ability of the blastocyst to synthesize and release oestrogen during this period (Perry et al., 1973; Gadsby et al., 1980; Geisert et al., 1982b ) is presumed to be the 'maternal recognition' signal which results in extended luteal function (see Bazer et al., 1984 for review) .
Exogenous oestrogen administration between Days 11 and 15 of the oestrous cycle prolongs luteal function (pseudopregnancy) in the pig (Gardner et al., 1963; Frank et al., 1977; Saunders et al., 1983) . In gilts, daily administration of 5 mg oestradiol valerate from Days 11 through 15 of the oestrous cycle extends the interoestrous interval to more than 50 days (Frank et al., 1977) . Geisert et al. (1982c) indicated that a single 5 mg i.m. injection of oestradiol valerate on Day 11 of the oestrous cycle produced an increase in uterine luminal content of calcium, protein and acid phosphatase activity similar to that obtained after oestrogen release by elongating blastocysts during early pregnancy (Geisert et al., 1982a, b) . Although a single oestrogen injection appeared to mimic the uterine response which occurs on Days 11\p=n-\12 of pregnancy, the effect on inducing prolonged luteal function has not been clearly determined.
Blastocysts must reach the developmental stage at which they are able to synthesize the oestrogen (Geisert et al., 1982b) that stimulates the uterine endometrium and prevents CL regression. Concurrently, the endometrium has to reach a developmental stage which is responsive to oestrogen release by the elongating blastocyst. Previous studies have indicated that oestrogen administration before Day 10 and after Day 16 failed to induce prolonged CL function in gilts (Kidder et al., 1955; Gardner et al., 1963) . In addition, low doses of oestrogen given either subcutaneously or through intrauterine infusion from Day 10 to 14 of the oestrous cycle failed to extend CL function beyond Day 24 (Saunders et al., 1983) . These studies suggest that the uterine endometrium may not only be responsive to oestrogen during discrete periods ofthe oestrous cycle, but the magnitude ofstimulation may also play an important role in CL maintenance.
The following study was carried out to establish ( 1 ) the time and duration of exogenous oestrogen administration needed to induce prolonged luteal function in the gilt and (2) Hormone radioimmunoassay. Plasma progesterone concentrations were quantified in duplicate by radioimmuno¬ assay as previously described (Hallford et a!, 1975) . The sensitivity of the assay by this procedure was 01 ng/ml. Intra-and inter-assay coefficients of variation were 10-6% and 8-6%, respectively.
Prostaglandin concentrations in uterine flushings were measured by a double-antibody radioimmunoassay using the procedures previously described by Geisert et a! (1986) . The PGF-2a antiserum (gift from Dr K. T. Kirton, Upjohn Company, Kalamazoo, MI, U.S.A.) cross-reacted <01% with PGA, PGA-2, PGB, PGB-2, PGE-2, PGE-3; < I % for 15-keto PGF-2a and 8% for PGF-la (Cornette et a!, 1972 (Alexander, 1971 ).
Uterine protein and acid phosphatase activity. Protein concentration in uterine flushings was determined by the method of Lowry et a! (1951) . Acid phosphatase activity was determined, using /i-nitrophenyl-phosphate as the substrate as previously described by Basha et a! (1979) . One unit of activity was defined as the capacity to release 1 pmol />-nitrophenol per min at pH 4-9 in 0-1 M-acetate buffer.
Two-dimensionalpoiyacrylamide gel electrophoresis (PAGE) . Qualitative changes in protein collected in uterine flushings were analysed by 2-dimensional PAGE. Uterine flushings (2 mg protein) were dialysed (molecular weight cut-off 8 3500) against several volumes of 1 mM-Tris-HCl buffer (pH 8-2). After lyophilization, the dialysed uterine protein was prepared for PAGE by being directly dissolved in 1 ml 5 mM-K2C03 containing 9-4M-urea, 2% (v/v) Nonidet P-40 and 0-5% (w/v) dithiothreitol. The PAGE was performed (300 pg protein loaded) for acidic and basic proteins according to the method described by Basha et (Gill & Hafs, 1971 (Fig. 1) Profiles of acidic polypeptides present in the uterine flushing from a vehicle-and an oestradiol benzoate-treated gilt are illustrated in Fig. 2 . Serum albumin was the major protein present in all flushings along with the appearance of two additional non-serum proteins (MT = 18 000, pH 6-6-6-3) on Days 12 and 14-5 of the oestrous cycle ( Fig. 2b and 2c ). These two acidic polypeptides were not detectable in gels from vehicle-or oestradiol benzoate-treated gilts on Day 10 (Fig. 2a) .
Basic polypeptides isolated by PAGE which were detected in uterine flushings of oestradioland vehicle-treated gilts are presented in Fig. 3 . Uteroferrin (Mr = 35 000; pH = 7-2) is indicated by the letter U and two other nonserum proteins (Mt = 50 000-60 000; pH 7-2) located above uteroferrin appear after Day (Fig. 3b ), but were undetectable on Day 10 in vehicle-and oestradiol-treated gilts (Fig. 3a) . Although these polypeptides are present in flushings from all gilts on Days 11-5 and 14, oestradiol benzoate treatment appeared to intensify their presence on Day (Fig. 3c) . Another complex of low molecular weight (MT = 14 500) polypeptides which have been identified as a family of plasmin isoinhibitors (Fazleabas et al. 1983) , was also intensified after oestradiol benzoate treatment on Day 11*5.
Experiment 4
As shown in Table 3 , treatment by day interactions were detected for calcium (P < 008), and acid phosphatase activity (P < 001). Acid phosphatase specific activity was affected by treatment The two low molecular weight (M, = 18 000) acidic polypeptides described in Exp. 3 were present in the uterine flushings of vehicle-and oestradiol-treated gilts on Days 11 and 12. However, oestrogen administration on Day 9-5 apparently modified the staining intensity of these two poly¬ peptides compared with that in vehicle-treated gilts (Fig. 2d) . The administration of oestrogen on Day 9-5 appeared to enhance the staining intensity of these two polypeptides so that their visual appearance was even greater than that seen on Day 14 (Fig. 2c) (1983) . Although the oestrogen treatments given in the present study are pharmacological, physiologically a similar change in blastocyst oestrogen secretion has been observed during pregnancy (Robertson et ai, 1978; Bazer et ai, 1982; Stone & Seamark, 1985) . The secondary sustained increase in blastocyst oestrogen secretion also appears to be involved with continued CL maintenance since flushing embryos from one uterine horn before Day 18 is not as effective in allowing maintenance of a unilateral pregnancy as flushing embryos on or after Day 18 (Dhindsa & Dziuk, 1968 (Geisert et ai, 1982c; present study), similar to that which occurs upon blastocyst oestrogen release (Geisert et ai, 1982b) . Although the interoestrous interval is extended by oestradiol benzoate treatment on Day 9-5, the results in Exp. 4 suggest that this response may have been stimulated by a residual effect as a consequence of the pharmacological levels of oestrogen still present on Day 11. It appears that the uterine endometrial secretion of calcium and protein is not responsive to oestrogen until after the 10th day of the oestrous cycle (Exp. 3), which would be in agreement with the normal synchrony of development and blastocyst oestrogen release (Geisert et ai, 1982b) . Lack of oestradiol stimulated release of uteroferrin and an increase in acid phosphatase activity in uterine flushings before Day 10 would indicate that secretory development was not completed. This is consistent with the lack of positive immunological staining for uteroferrin in the glandular epithelium until after Day 10 of the oestrous cycle (Renegar, 1982) .
Identification of the two acidic (pH 5-4) polypeptides in Day 12 uterine flushings after oestrogen treatment on Day 9-5 is of interest. Pope & First (1985) indicated that gilts administered oestrogen on Day 9 and 10 failed to maintain pregnancy to Day 30. At present, biological significance of the acidic polypeptides is unknown. In view of our results and those of Pope & First (1985) additional studies are needed to ascertain the possible role of these polypeptides in conceptus development and survival.
Further studies are needed to clarify the possible involvement of the two oestrogen phases in PGF movement , synthesis (Guthrie & Rexroad, 1981) and direct effects on CL function (Kraeling et ai, 1975 
